NCI U01 Award


Congratulations, Drs. Damaghi and Silva!


Drs. Mehdi Damaghi and Ariosto Silva (MPI) were awarded an NCI U01 of $3,417,517 over five years for their research project titled "Ecology and Evolution of Breast Carcinogenesis." Drs. Marilyn Bui, Brian Czerniecki, Robert Gatenby and Robert Gillies will serve as Co-Investigators on the project.


October 13th, 2021





Drs. Ariosto Silva and Mehdi Damaghi

Creation of Pentecost Family Myeloma Research Center at Moffitt

Drs. Baz, Silva and Shain are honored to be part of this enterprise


 August 13th, 2021




Our story by Moffitt Endeavor


Mathematical Program Can Dictate Multiple Myeloma Therapy


March 19th, 2021 



2021 Moffitt Symposium

Dynamic Epigenetic Landscapes are Associated with Multiple Myeloma Progression and Resistance

 (Poster) (Pre-print)

April 28th, 2021

2021 Moffitt Symposium

A Multiomic Approach to Mathematical Modeling of Gene Regulatory Networks in Multiple Myeloma


April 28th, 2021





   MM is a type o cancer that forms derived from plasma cells, found in the bone marrow, and these affected cells start producing abnormal proteins rather than helpful antibodies.

  Complications in the body are due to its uncontrolled cell proliferation, however not always treatment is required when MM has a slow growth. When treatment is required most patients rely on their doctors’ expertise to choose the right course of treatment.

   Not all patients have predictable responses to treatment and when personalized approach is used doctors can select the right time and the right course of regimen individually rather than a broad approach.